Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 2008 | 2 | 0.330 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 198 | 0.280 |
Why?
|
| Diphosphonates | 1 | 2008 | 262 | 0.280 |
Why?
|
| Imidazoles | 1 | 2008 | 999 | 0.210 |
Why?
|
| Quadriplegia | 1 | 2002 | 43 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2002 | 90 | 0.200 |
Why?
|
| Cytarabine | 1 | 2002 | 1973 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 1375 | 0.130 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2008 | 34 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 7702 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2003 | 242 | 0.050 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 216 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2002 | 257 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 251 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2003 | 154 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2003 | 842 | 0.040 |
Why?
|
| Military Personnel | 1 | 2002 | 225 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2003 | 554 | 0.040 |
Why?
|
| Vidarabine | 1 | 2003 | 1341 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2003 | 1270 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2003 | 1303 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2003 | 1870 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2002 | 2796 | 0.020 |
Why?
|
| Middle Aged | 3 | 2008 | 86204 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 11538 | 0.020 |
Why?
|
| Platelet Count | 1 | 2003 | 490 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 684 | 0.010 |
Why?
|
| Adult | 3 | 2003 | 77950 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2003 | 593 | 0.010 |
Why?
|
| Humans | 4 | 2008 | 261506 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 415 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 299 | 0.010 |
Why?
|
| Female | 3 | 2008 | 141928 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 835 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 2003 | 587 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2003 | 585 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2003 | 12873 | 0.010 |
Why?
|
| Male | 3 | 2003 | 123000 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2003 | 713 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 3569 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2003 | 3001 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 830 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 1362 | 0.010 |
Why?
|
| Texas | 1 | 2003 | 6311 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2003 | 2390 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12221 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 12926 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 37905 | 0.000 |
Why?
|